GO Term |
---|
embryonic hindlimb morphogenesis |
regulation of canonical Wnt signaling pathway |
negative regulation of canonical Wnt signaling pathway |
positive regulation of canonical Wnt signaling pathway |
GO Term |
---|
extracellular region |
plasma membrane |
collagen-containing extracellular matrix |
endoplasmic reticulum lumen |
Golgi lumen |
cell surface |
side of membrane |
lysosomal lumen |
GO Term |
---|
peptidyl-dipeptidase inhibitor activity |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
124 | N-linked (GlcNAc...) asparagine | |||
241 | N-linked (GlcNAc...) asparagine | |||
359 |
|
|||
418 | N-linked (GlcNAc...) asparagine |
|
||
495 | O-linked (Xyl...) (glycosaminoglycan) serine |
|
||
509 | O-linked (Xyl...) (glycosaminoglycan) serine |
|
||
|
Pathway Name | Organism |
---|---|
A tetrasaccharide linker sequence is required for GAG synthesis | Homo sapiens |
Attachment and Entry | Homo sapiens |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | Homo sapiens |
Defective B3GAT3 causes JDSSDHD | Homo sapiens |
Defective B4GALT7 causes EDS, progeroid type | Homo sapiens |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | Homo sapiens |
Defective EXT2 causes exostoses 2 | Homo sapiens |
HS-GAG biosynthesis | Homo sapiens |
HS-GAG degradation | Homo sapiens |
Post-translational protein phosphorylation | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:2394 | ovarian cancer | |
DOID:2512 | nevoid basal cell carcinoma syndrome | |
DOID:2513 | basal cell carcinoma | |
DOID:2590 | familial nephrotic syndrome | |
DOID:2645 | benign mesothelioma | |
DOID:2785 | Dandy-Walker syndrome | |
DOID:2871 | endometrial carcinoma | |
DOID:2891 | thyroid adenoma | |
DOID:2893 | cervix carcinoma | |
DOID:2914 | immune system disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024